In the current study, we developed an Ad6-based vector expressing human GM-CSF, Ad6-d24-GM, and examined its anti-tumor potential in a novel immunocompetent and viral replication-permissive Syrian hamster CCA-OF model. This evidence concerns the gene CSF2 and neoplasm.